Interdisciplinary Collaboration in Head and Neck Cancer Care: Optimizing Oral Health Management for Patients Undergoing Radiation Therapy
Source : https://pubmed.ncbi.nlm.nih.gov/38668058/
Radiation therapy (RT) plays a crucial role in the treatment of head and neck cancers (HNCs). This paper emphasizes the importance of effective communication and collaboration between radiation oncologists and...
Effective collaboration between radiation oncologists and dental specialists optimizes head and neck cancer treatment, reducing RT-induced oral complications through early dental assessment and ongoing oral health management.
Re-re-irradiation for palliation: knowns, unknowns, and next steps
Source : https://pubmed.ncbi.nlm.nih.gov/38988081/
With improving rates of survival among patients with metastatic malignancies, the request for palliative re-irradiation and re-re-irradiation continues to grow despite an absence of standardized guidelines. With only limited data...
Limited studies suggest extra-cranial third-course palliative radiation offers effective pain relief with low toxicity, but careful patient selection and advanced techniques are essential.
Radiation Therapy and Myeloid-Derived Suppressor Cells: Breaking Down Their Cancerous Partnership
Source : https://pubmed.ncbi.nlm.nih.gov/38042450/
Radiation therapy (RT) has been a primary treatment modality in cancer for decades. Increasing evidence suggests that RT can induce an immunosuppressive shift via upregulation of cells such as tumor-associated...
Radiation therapy can enhance tumor resistance by activating immunosuppressive MDSCs in the TME, promoting therapeutic resistance. Personalized approaches in radiation therapy improve outcomes in breast cancer management.
Personalized Radiation Therapy for Breast Cancer
Source : https://pubmed.ncbi.nlm.nih.gov/38534954/
Breast cancer is diagnosed in nearly 3 million people worldwide. Radiation therapy is an integral component of disease management for patients with breast cancer, and is used after breast-conserving surgery...
Personalizing breast cancer radiation therapy enhances treatment efficacy by optimizing patient selection, using advanced techniques to protect normal tissues, and implementing hypofractionation to reduce treatment duration.
Clinical Outcomes of PD-1/PD-L1 Inhibitors Among Patients With Advanced or Metastatic Non-Small Cell Lung Cancer With BRAF, ERBB2/HER2, MET , or RET Alterations: A Systematic Literature Review
Source : https://pubmed.ncbi.nlm.nih.gov/38112201/
The therapeutic landscape for patients with advanced or metastatic non-small cell lung cancer (NSCLC) is rapidly evolving due to advances in molecular testing and the development of new targeted therapies...
Additional prospective studies are needed to assess the efficacy of PD-1/PD-L1 inhibitors in NSCLC patients with BRAF V600E mutation, HER2/ERBB2 alteration, MET exon 14 skipping mutation, or RET rearrangement, considering heterogeneity in current evidence.